Fucheng Qu
8Patents
4h-index
16Co-inventors
54Inventor score
Filing activity: Nov 15, 1996 → Jun 19, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5792773A | L-.beta.-dioxolane uridine analog administration for treating Epstein-Barr virus infection | Chemistry; Metallurgy | 17 | Expired |
| US7846960B2 | FXR agonists | Chemistry; Metallurgy | 15 | Active |
| US6022876A | L-.beta.-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections | Human Necessities | 8 | Expired |
| US6274589A | L-.beta.-dioxolane uridine analogs and their pharmaceutical compositions | Human Necessities | 4 | Expired |
| US8697849B2 | Pyrazole compounds | Chemistry; Metallurgy | 4 | Active |
| US8785404B2 | Urea compounds | Chemistry; Metallurgy | 2 | Active |
| US9296775B2 | Pyrazole compounds | Chemistry; Metallurgy | 1 | Active |
| US11655242B2 | Glucagon-like peptide1 receptor agonists | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.